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Prevalence of six types ofhuman papillomavirus
in inverted papilloma and papillary transitional
cell carcinoma of the bladder: an evaluation by
polymerase chain reaction
KW Chan, K Y Wong, G Srivastava
Abstract
Aims-To study the prevalence of high
risk oncogenic human papillomaviruses
(HPV) in inverted papilloma and papil-
lary transitional cell carcinoma of the
bladder.
Methods-Ten cases ofinverted papilloma
and 20 cases of papillary transitional cell
carcinoma of the bladder from Chinese
patients in Hong Kong were examined for
the presence of HPV type 6, 11, 16, 18, 31,
and 33 genomes using the polymerase
chain reaction and HPV type specific
primer probe combinations on paraffin
wax embedded biopsy specimens.
Results-Of the 10 cases ofinverted papil-
loma, cases 1 and 6 showed the presence of
HPV types 16 and 18, respectively. Six of
the 20 papillary transitional cell carcino-
mas were positive for HPV type 18. The
other HPV types were not detected.
Conclusions-HPV type 18 was found in
60% and 30% of cases of inverted papil-
loma and papillary transitional cell carci-
noma of the bladder, respectively. These
tumours were rarely associated with HPV
types 6, 11, 16, 31, and 33. The role ofHPV
type 18 in oncogenesis of inverted papil-
loma and transitional cell carcinoma of
the bladder requires further studies.
(J Clin Pathol 1997;50:1018-1021)
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Inverted papilloma of the urinary tract is an
uncommon benign tumour of the transitional
cell epithelium usually found in the urinary
bladder. It is characterised by an invaginating
growth of transitional cell epithelium that
shows no cytological atypia. Little is known
about the aetiology of inverted papilloma. The
occasional coexistence of inverted papilloma
and transitional cell carcinoma suggests a
pathogenetic relation.' 2 Early work firmly
established the role of chemical carcinogens in
the pathogenesis of transitional cell carcinoma
of the bladder. Recently, an association be-
tween oncogenic human papillomaviruses
(HPV) and transitional cell carcinoma of the
bladder has been reported repeatedly.3'-0 How-
ever, the prevalence of oncogenic HPV in tran-
sitional cell carcinoma was unknown in Hong
Kong and the status of oncogenic HPV in
inverted papilloma was never studied. There-
fore, using the polymerase chain reaction
(PCR), we set out to test cases of papillary
transitional cell carcinoma and inverted papil-
loma for the types of HPV that are most com-
monly studied in association with human geni-
tourinary tumours. The PCR method was
selected because of its sensitivity and specificity
and its suitability for use on small, paraffin wax
embedded biopsy specimens.
Methods
The biopsy and surgical files of the department
of pathology, University of Hong Kong at the
Queen Mary Hospital in the years 1987-94
were searched for cases of inverted papilloma
of the bladder; 14 patients were identified.
These cases were the subject of a previous
immunohistological study on p53 overexpres-
sion in inverted papilloma of the bladder."
Twenty cases of papillary transitional cell
carcinoma of grades I and II obtained through
endoscopic biopsy and without evidence of
invasion of the bladder wall were selected ran-
domly from the same files. The clinical history
as recorded on the pathology request form was
noted. The slides were reviewed and the origi-
nal diagnoses confirmed.
DNA was extracted from routinely proc-
essed, formalin fixed, paraffin wax embedded
tumour tissues." Four cases of inverted papil-
loma of the bladder were excluded owing to
insufficient tissue remaining. The quality of
DNA extracted was verified by amplifying the 1
globin gene.'3 Detection of HPV DNA was
performed by PCR using type specific DNA
primer probe combinations for HPV types 6,'4
1 1,'5 16,16 18,'5 31,'4 and 33.14 The oligonucle-
otide primers used in the PCR for HPV type 16
were complementary to the upstream regula-
tory region of the viral DNA, while for HPV
type 18 they were complementary to sequences
in the E6 region. The hybridisation and wash-
ing conditions were identical to those reported
previously by our laboratory.'2 Positive controls
were performed. Cell lines, used as controls to
determine the specificity of the PCR proce-
dures, were obtained from American Type
Culture Collection, Maryland, USA. They
included: (a) CaSki (400-500 copies of HPV
type 16 per cell), (b) SiHa (1-2 copies ofHPV
type 16 per cell), and (c) HeLa (10-50 copies
of HPV type 18 per cell). To determine the
sensitivity of the PCR procedures in detecting
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SiHa CaSki 9 8
228 bp -.-
1) Globin
SiHa CaSki 9 8 7 6
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Figure 1 (A) Amplification ofHPVtype 16 DNA in inverted p
negative result for cases 7-9. Other inverted papilloma samples sho
DNA (from an Epstein-Barr virus infected cell line) and distilled
controls. SiHa and CaSki are HPV type 16 infected cell lines used
(B) Amplification of the fi globin gene in samples ofDNA used in
of25 ng ofDNA from the control cell lines and 500 ng ofDNA fr
for the PCR analysis.
Inverted transitional papilloma
HeLa 1 2 3 4 5 6 7 8
100 1p2 3 4 5 6 7
Transitional cell carcinoma
HeLa 2 3 4 5 6
HeLa 10 11 12 13 14 15 16
Figure 2 (A) PCR amplification ofHPV type 18 DNA is dem
papilloma cases 1, 2, 3, 5, 7, and 9. HeLa cells and distilled water
negative controls. Lanes 10 and 11 are samples from two paraffin
(B) Six of the 20 cases of transitional cell carcinoma (numbered 1
show the presence ofHPV type 18 DNA. Aliquots of 25 ng ofDN
and 500 ng ofDNA from each sample were usedfor the PCR ana
Table 1 Demographic data and tumour sizes of 10 cases of inver
bladder
Case Age (years) Sex HPV16 HPV18 p53 sc
1 39 M - + 3+
2 52 M - + 3+
3 75 M - + 3+
4 56 M - 1+
5 56 F - + 2+
6 75 M + 0
7 43 F - + 2+
8 42 M - - 2+
9 77 F - + 0
10 68 M - - 0
HPV types 16 and 18 DNA, varying amounts
6 H2O Raji of DNA (0.1 pg to 1 jg) from the control cell
lines were amplified and hybridised. Distilled
water was used as a negative control in each set
Sp* of PCR reactions. Control primers for ,B globin
were amplified successfully in these PCR reac-
tions, verifying that there were no inhibitory
elements present in the extracted DNA.
The HPV status in each inverted papilloma
was correlated with its p53 score obtained
previously." The methodology for p53 scoring
has been described before. Briefly, scoring of
p53 was performed on high power fields (x400)
using a standard light microscope. The per-
H20 Raji centage of p53 positive cases was determined
by counting 500 cells and the cases were sepa-
rated into four categories: 0, when fewer than
10% of the tumour cells were positive; 1+,
I:swhen 10% to fewer than 30% tumour cells
were positive; 2+, when 30-50% of the tumour
cells were positive; and 3+, when more than
50% of the tumour cells were positive.
Papilloma case 6 and a Statistical analysis was performed using the
iw no amplification. Raji Fisher's exact test and x2 test as appropriate.
water served as negative
as positive controls.
the above study. Aliquots Results
rom each sample was used HPV type 18 was the only one shown to infect
papillary transitional cell carcinoma and was
present in six of the 20 cases. Of the 10 cases of
inverted papilloma, HPV types 16 and 18 were
detected in cases 1 (fig 1) and 6 (fig 2), respec-
9 10 11 H2O tively. The demographic data, status of HPV
infection, p53 score," and tumour size of the
10 cases of inverted papilloma of the bladder
_ are shown in table 1.' No significant differencein the prevalence of HPV type 18 positivity
could be demonstrated between inverted papil-
loma and papillary transitional cell carcinoma
of the bladder (p > 0.1, Fisher's exact test).
PCR analysis for the detection ofHPV types
7 8 9 H2O 16 and 18 specific DNA sequences on DNA
extracted from the CaSki and SiHa cell lines
(for HPV type 16) and the HeLa cell line (for
HPV type 18) yielded a detectable hybridisa-
tion signal using a minimum of 25 ng of DNA
from the control cell lines. These results were
17 18 19 20 considered adequate for the analysis of the
* tumour samples.
Discussion
onstrated in inverted HPV type 18 was the prevalent oncogenic HPV
are the positive and found in patients with a transitional cell
blocks of the same case. neoplasm of the urinary bladder. High risk
A from the HeLa cell line oncogenic types of HPV have been frequently
lysis. reported to be associated with transitional cell
carcinoma of the bladder.3-'0 The molecular
techniques used in HPV detection included
'ted papilloma of the Southern blot hybridisation, PCR, and in situ
hybridisation. Table 2 summarises the results
Tumour size of studies conducted in several centres, includ-
core" (mM) ing ours. The prevalence of oncogenic HPV in
transitional cell carcinoma of the bladder
12 among different studies was highly variable and
4 it was difficult to identify the reasons for this
12 wide variation. The variations could be due to:
10 (a) different types and stages of transitional cell
10 carcinoma, (b) geographical differences in the
4 incidence ofHPV infection, and (c) the differ-
10 ent sensitivities of the various methods of
detection used. When we selected cases of
1 1 0 )p -
100 hp*-
100 bp-.-
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Table 2 Summary of the prevalence of high risk oncogenic HPV in transitional cell carcinoma of the bladder
Reference Method HPV6 HPVII HPV16 HPV18 HPV31 HPV33
Bryant et at' ISH 0/76 12/76 /0 /0
Anwar et alP PCR 22/48 13/48 18/48 /0 14/48
Shibutani et al' SoBH 2/20 1/20 1/20
Yu et al' PCR /0 /0 28/53 2/53 /0 /0
Furihata et at' ISH /0 /0 19/90 17/90 /0 16/90
Kamel et al' ISH 12/40 10/40 8/40 16/40 16/40 12/40
Lopes Beltran and Munoz' PCR 1/76 0/76 7/76 0/76 /0 /0
Tenti et al" PCR 0/79 12/76 0/76
Present study PCR 0/20 0/20 0/20 6/20 0/20 0/20
ISH, in situ hybridisation; PCR, polymerase chain reaction; SoBH, Southern blot hybridisation.
transitional cell carcinoma for this study we
had considered the possible effects of the first
variable on the results and tried to homogenise
the selection by choosing only non-invasive
papillary carcinomas of lower grades. A geo-
graphical difference of incidence ofHPV infec-
tion is difficult to document because this would
require the analysis of tissue samples collected
from different countries by the same tech-
niques and, ideally, by the same laboratory. It
would be of interest to take note of the
prevalence of HPV infection in cervical carci-
nomas in our population. A report from this
hospital showed that HPV types 16 and 18,
respectively, could be detected in 62% and
39% of 64 cases of squamous cell carcinoma of
the cervix.'7 The prevalence ofHPV type 16 in
cervical squamous cell carcinoma is signifi-
cantly higher than that of both inverted
papilloma and transitional cell carcinoma of
the bladder (p < 0.01, Fisher's exact test). On
the other hand, no significant difference can be
demonstrated between the prevalence of HPV
type 18 in cervical squamous cell carcinoma
and transitional cell carcinoma of the bladder
or between that in cervical squamous cell
carcinoma and inverted papilloma of the blad-
der (p > 0.05, x' test). The reasons for the pre-
dilection ofHPV type 16 infection in cancers of
the female genital tract over that of the lower
urinary tract in our population are unknown.
To our knowledge, there has been no
previous study on the prevalence of HPV in
inverted papilloma of the bladder. Our results
show that HPV type 18 could be detected in
60% of cases of inverted papilloma of the blad-
der. Although the prevalence ofHPV type 18 in
inverted papilloma appears to be twice that
seen in papillary transitional cell carcinoma,
the difference fails to reach statistical signifi-
cance. Studies on many more cases would be
required to clarify whether HPV type 18 is
more frequent in inverted papilloma than in
papillary transitional cell carcinoma of the
bladder.
Our results show that HPV types 6, 11, 16,
31, and 33 are rarely associated with transi-
tional cell tumours of the bladder and that they
play little or no role in the pathogenesis of these
tumours in Hong Kong.
The p53 gene encodes a 53 kDa nuclear
phosphoprotein that is a suppressor of cell
growth.'8 '9 It is associated with control of the
cell cycle, DNA repair and synthesis, cell
differentiation, genomic plasticity, and apopto-
sis. Mutation of the p53 suppressor gene is the
most common genetic alteration in human
cancer.'8 Binding of HPV E6 and E7 proteins
to p53 may result in a loss of tumour suppres-
sor activity.20 Thus, an inverse relation between
p53 expression and certain HPV types, espe-
cially types 16 and 18, was found in cases of
cervical carcinoma.2' HPV infection in transi-
tional cell carcinoma was correlated with p53
overexpression in several studies.7 "'1 Furihata
et ar found that p53 overexpression was more
common in invasive and non-papillary tu-
mours than in high grade tumours. In contrast,
HPV infection was found to be more common
in non-invasive and papillary tumours. Similar
findings were obtained by Tenti et al,'0 who
found that p53 accumulation was more fre-
quent in high grade transitional cell carcinoma
than in low grade tumours, and that HPV
infection was more common in low grade tran-
sitional cell carcinomas than those of a high
grade. Kamel et al,' on the other hand, could
find no inverse relation between HPV positivity
and p53 accumulation in transitional cell
carcinoma of the bladder.
Our study is the first to correlate HPV infec-
tion and p53 expression in inverted papilloma.
We found that five of the six cases of inverted
papilloma with demonstrable HPV type 18 had
a p53 score of 2+ or higher. On the other hand,
two of the four HPV type 18 negative cases of
inverted papilloma showed a p53 score of 0.
Although the number of cases of inverted pap-
illoma are small, the result suggests a positive
correlation between accumulation of p53 and
HPV type 18 infection. This is notably
different from the inverse correlation between
the latter two that has been found by some
investigators in cervical cancer2' and transi-
tional cell carcinoma.7 '" HPV type 18 may play
a role in the pathogenesis of inverted papilloma
by some mechanisms other than inactivation of
the p53 protein.
This study was supported by a research grant (CRCG 335/046/
0048) of The University of Hong Kong.
1 Lazarevic B, Garret R. Inverted papilloma and papillary
transitional cell carcinoma of urinary bladder. Report of
four cases of inverted papilloma, one showing papillary
malignant transformation and review of the literature. Can-
cer 1978;42:1904-1 1.
2 Anderstrom C, Johansson S, Pattersson S. Inverted
papilloma of the urinary tract.
_J Urol 1982;127:1 132-4.
3 Bryant P, Davies P, Wilson D. Detection of human papillo-
mavirus DNA in cancer of the urinary bladder by in situ
hybridisation. BrJ Urol 1991;68:49-52.
4 Anwar K, Naiki H, Nakakuki K, Inuzuka M. High
frequency ofhuman papillomavirus infection in carcinoma
of the urinary bladder. Cancer 1992;70:1967-73.
5 Shibutani YF, Schoenberg MP, Carpiniello VL, Malloy TR.
Human papillomavirus associated with bladder cancer.
Urology 1992;40:15-17.
6 Yu ST, Wu MM, Li LM. Prevalence of human papillomavi-
ruses 16 and 18 in transitional cell carcinoma of bladder.
Chin Medj Engl 1993;106:494-6.
7 Furihata M, Inoue K, Ohtsuki Y, Hashimoto H, Terao N,
Fujita Y. High-risk human papillomavirus infections and
1020
HPV in papilloma and carcinoma of the bladder
overexpression of p53 protein as prognostic indicators in
transitional cell carcinoma of the urinary bladder. Cancer
Res 1993;53:4823-7.
8 Kamel D, Paakko P, Pollanen R, Vahakangas K, Lehto VP,
Soini Y. Human papillomavirus DNA and abnormal p53
expression in carcinoma of the urinary bladder. APMIS
1995;103:331-8.
9 Lopez Beltran A, Munoz E. Transitional cell carcinoma of
the bladder: low incidence of human papillomavirus DNA
detected by the polymerase chain reaction and in situ
hybridization. Histopathology 1995;26:565-9.
10 Tenti P, Zappatore R, Romagnoli S, Civardi E, Giunta P,
Scelsi R, et al. p53 overexpression and human papillomavi-
rus infection in transitional cell carcinoma of the urinary
bladder: correlation with histological parameters. I Pathol
1996;178;65-70.
11 Chan KW, Lam KY, Srivastava G. Accumulation of p53
protein in inverted transitional cell papilloma of urinary
bladder. Clin Pathol:Mol Pathol 1996;49:M43-5.
12 Chan KW, Lam KY, Chan ACL, Lau P, Srivastava G.
Prevalence of human papillomavirus types 16 and 18 in
penile carcinoma: a study of 41 cases using PCR. Clin
Pathol 1994;47:823-6.
13 Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich
HA, et al. Enzymatic amplification of beta-globin genomic
sequences and restriction site analysis for diagnosis of
sickle cell anemia. Science 1985;230:1350-4.
14 Van Den Brule AJ, Walboomers JM, Du Maine M,
Kenemans P, Meijer CJ. Difference in prevalence of
human papillomavirus genotypes in cytomorphologically
normal cervical smears is associated with a history of
cervical intraepithelial neoplasia. Int Jf Cancer 1991;48:
404-8.
15 Young LS, Bevan IS, Johnson MA, Blomfield PI, Bromidge
T, Maitland NJ, et al. The polymerase chain reaction: a new
epidemiological tool for investigating cervical human pap-
illomavirus infection. BMJ 1989;298:14-18.
16 Tidy JA, Farrell PJ, Vousden KH. Relation between
infection with a subtype of HPV1 6 and cervical neoplasia.
Lancet 1989;i:1225-7.
17 Nyan HY, Stanley M, Lu SS, Ma HK. HPV and p53 in cer-
vical cancer. Genitourin Med 1994;70: 167-70.
18 Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53
mutations in human cancers. Science 1991;253:49-53.
19 Vogelstein B, Kinzler KW. p53 function and dysfunction.
Cell 1992;70:523-6.
20 Scheffner M, Werness B, Huibregtse JM, Levine AJ, Howley
PM. The EG oncoprotein encoded by human papillomavi-
rus type 16 and 18 promotes the degradation of p53. Cell
1990;63:1129-36.
21 Lorincz AT, Temple GF, Kurman RJ, Jenson AB, Lancaster
WD. Oncogene association of specific human papillomavi-
rus types with cervical neoplasia.
_7 Natl Cancer Inst
1987;79:671-7
1021
